Prakash Kumar Shukla

Prakash Kumar Shukla

Auto-generated profile, based on publicly available information

Prakash Kumar Shukla

Affiliation Centre for Bio-Separation Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
MSMau Sinha
Mau Sinha
LGLovely Gautam
Lovely Gautam
PSPrakash Kumar Shukla
Prakash Kumar Shukla
PKPunit Kaur
Punit Kaur
SSSujata Sharma
Sujata Sharma
TSTej Singh
Tej Singh
Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most highly prescribed drugs in the world. Their analgesic, anti-inflammatory, and antipyretic actions may be beneficial; however, they are associated with severe side effects including gastrointestinal injury and peptic ulceration. Though several approaches for limiting these side effects have been adopted, like the use of COX-2 specific drugs, comedication of acid suppressants like proton pump inhibitors and prostaglandin analogs, these alternatives have limitations in terms of efficacy and side effects. In this paper, the mechanism of action of NSAIDs and their critical gastrointestinal complications have been reviewed. This paper also provides the information on different preventive measures prescribed to minimize such adverse effects and analyses the new suggested strategies for development of novel drugs to maintain the anti-inflammatory functions of NSAIDs along with effective gastrointestinal protection.

1 April 2015 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
PSPrakash Kumar Shukla
Prakash Kumar Shukla
LGLovely Gautam
Lovely Gautam
MSMau Sinha
Mau Sinha
PKPunit Kaur
Punit Kaur
SSSujata Sharma
Sujata Sharma
TSTej Singh
Tej Singh

20 September 2024 in Chemical Physics Impact
Verified
Journal Article
Open access
MKMukesh Kumar
Mukesh Kumar
VSVikas Srivastava
Vikas Srivastava
UDUma Devi
Uma Devi
KNKhemRaj Nackwal
KhemRaj Nackwal
MAMohammad Z. Ahmed
Mohammad Z. Ahmed
PSPrakash K. Shukla
Prakash K. Shukla

23 September 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PSPrakash K. Shukla
Prakash K. Shukla
DSDhiraj Sinha
Dhiraj Sinha
ALAndrew M. Leng
Andrew M. Leng
JBJesse E. Bissell
Jesse E. Bissell
STShravya Thatipamula
Shravya Thatipamula
MCMahesh B Chandrasekharan
Mahesh B Chandrasekharan
Rad6, an E2 ubiquitin-conjugating enzyme conserved from yeast to humans, functions in transcription, genome maintenance, and proteostasis. The contributions of many conserved secondary structures of Rad6 and its human homologs UBE2A and UBE2B to their biological functions are not understood. A mutant RAD6 allele with a missense substitution at alanine-126 (A126) of helix-3 that causes defects in telomeric gene silencing, DNA repair, and protein degradation was reported over 2 decades ago. Here, using a combination of genetics, biochemical, biophysical, and computational approaches, we discovered that helix-3 A126 mutations compromise the ability of Rad6 to ubiquitinate target proteins without disrupting interactions with partner E3 ubiquitin-ligases that are required for their various biological functions in vivo. Explaining the defective in vitro or in vivo ubiquitination activities, molecular dynamics simulations and NMR showed that helix-3 A126 mutations cause local disorder of the catalytic pocket of Rad6 in addition to disorganizing the global structure of the protein to decrease its stability in vivo. We also show that helix-3 A126 mutations deform the structures of UBE2A and UBE2B, the human Rad6 homologs, and compromise the in vitro ubiquitination activity and folding of UBE2B. Providing insights into their ubiquitination defects, we determined helix-3 A126 mutations impair the initial ubiquitin charging and the final discharging steps during substrate ubiquitination by Rad6. In summary, our studies reveal that the conserved helix-3 is a crucial structural constituent that controls the organization of catalytic pockets, enzymatic activities, and biological functions of the Rad6-family E2 ubiquitin-conjugating enzymes.

11 June 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
UDUma Devi
Uma Devi
PSPrakash K. Shukla
Prakash K. Shukla

1 September 2016 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
APAshutosh Pastor
Ashutosh Pastor
ASAmit K. Singh
Amit K. Singh
PSPrakash K. Shukla
Prakash K. Shukla
LLLarry Lemanski
Larry Lemanski
SMShikha T. Malik
Shikha T. Malik
TCTapan K. Chaudhuri
Tapan K. Chaudhuri